Source:http://linkedlifedata.com/resource/pubmed/id/16831090
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0019682,
umls-concept:C0019699,
umls-concept:C0030705,
umls-concept:C0087111,
umls-concept:C0205191,
umls-concept:C0443196,
umls-concept:C0871261,
umls-concept:C0887947,
umls-concept:C1511572,
umls-concept:C1512900,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2362651,
umls-concept:C2911692
|
pubmed:issue |
7
|
pubmed:dateCreated |
2006-7-11
|
pubmed:abstractText |
Little is known about the consequences of short cycles of structured treatment interruption or definitive interruption of HAART for both T cell subset dynamics and T lymphoproliferative responses (LPR). Immunological follow-up was performed in 45 early chronical HIV-1-infected patients during short STI cycles during the first 12 weeks after the definitive interruption of HAART (DTI) and, thereafter, until VL reached a plateau. During STI cycles, CD8(+), CD8(+), CD28(+), activation markers and naive CD4(+) T cells increased significantly (p < 0.0001), while both naive CD8(+) and memory CD4(+) T cells decreased. During DTI, CD8(+) CD28(+) T cells fell and CD4(+) naive T cells stabilized and the rest of the T cell subsets presented changes similar to those during STI cycles. Despite a transient increase in LPR to recall antigens and HIV proteins during STI cycles, LPR to polyclonal stimuli and pathogens decreased over the study. Differences in T cell subset dynamics and LPR observed throughout the study suggest that multiple exposures to low levels of antigen could improve the immune system, mainly by driving T cell maturation. Conversely, higher and longer viral replication after cessation of HAART overwhelms the immune system. These data may help to guide future immune-based therapies.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0889-2229
|
pubmed:author |
pubmed-author:ArnedoMireiaM,
pubmed-author:CastroPedroP,
pubmed-author:ClimentNuriaN,
pubmed-author:GallartTeresaT,
pubmed-author:GarcíaAnaA,
pubmed-author:GarciaFelipeF,
pubmed-author:GatellJosé MJM,
pubmed-author:LópezAnnaA,
pubmed-author:LiboisAgnèsA,
pubmed-author:MalenoMaría JMJ,
pubmed-author:PlanaMontserratM
|
pubmed:issnType |
Print
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
657-66
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16831090-Adult,
pubmed-meshheading:16831090-Antigens, CD28,
pubmed-meshheading:16831090-Antigens, CD57,
pubmed-meshheading:16831090-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:16831090-CD4-Positive T-Lymphocytes,
pubmed-meshheading:16831090-CD8-Positive T-Lymphocytes,
pubmed-meshheading:16831090-Female,
pubmed-meshheading:16831090-HIV Infections,
pubmed-meshheading:16831090-HIV-1,
pubmed-meshheading:16831090-Humans,
pubmed-meshheading:16831090-Immunity, Cellular,
pubmed-meshheading:16831090-Lymphocyte Activation,
pubmed-meshheading:16831090-Lymphocyte Count,
pubmed-meshheading:16831090-Male,
pubmed-meshheading:16831090-T-Lymphocyte Subsets,
pubmed-meshheading:16831090-Viral Load,
pubmed-meshheading:16831090-Virus Replication
|
pubmed:year |
2006
|
pubmed:articleTitle |
Dynamics of T cells subsets and lymphoproliferative responses during structured treatment interruption cycles and after definitive interruption of HAART in early chronic HIV type-1-infected patients.
|
pubmed:affiliation |
Infectious Diseases Unit, School of Medicine, University of Barcelona, Spain.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|